JIANGXI SANXIN MEDTEC CO.,LTD. Jiangxi Sanxin Medtec Co.,Ltd. Stock
Equities
300453
CNE100001ZJ1
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.33 CNY | -0.81% |
|
+1.38% | -3.93% |
| Sales 2022 | 1.34B 184M | Sales 2023 | 1.3B 179M | Capitalization | 3.96B 547M |
|---|---|---|---|---|---|
| Net income 2022 | 185M 25.53M | Net income 2023 | 207M 28.57M | EV / Sales 2022 | 2.39 x |
| Net cash position 2022 | 232M 32.01M | Net cash position 2023 | 160M 22.03M | EV / Sales 2023 | 2.93 x |
| P/E ratio 2022 |
18.5
x | P/E ratio 2023 |
19.2
x | Employees | 1,927 |
| Yield 2022 |
1.74% | Yield 2023 |
1.51% | Free-Float | 53.87% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.81% | ||
| 1 week | +1.38% | ||
| Current month | +0.55% | ||
| 1 month | +0.69% | ||
| 3 months | +7.01% | ||
| 6 months | -2.53% | ||
| Current year | -3.93% |
1 week
7.09
7.42
1 month
7.057.98
Current year
4.887.98
1 year
4.888.18
3 years
4.8813.52
5 years
3.2813.95
10 years
2.5016.38
| Managers | Title | Age | Since |
|---|---|---|---|
Bei Ting Zou
DFI | Director of Finance/CFO | 38 | 19-08-31 |
Zhi Ping Mao
PSD | President | 50 | 03-11-30 |
Yi Xing Peng
CHM | Chairman | 66 | 97-03-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lin Zhang
BRD | Director/Board Member | 41 | 01-12-31 |
Yi Xing Peng
CHM | Chairman | 66 | 97-03-06 |
Zhi Ping Mao
PSD | President | 50 | 03-11-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.08% | 12 M€ | -16.71% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 7.33 | -0.81% | 4,129,885 |
| 24-04-24 | 7.39 | +0.96% | 3,613,546 |
| 24-04-23 | 7.32 | +1.81% | 4,525,940 |
| 24-04-22 | 7.19 | -0.83% | 5,544,573 |
| 24-04-19 | 7.25 | +0.28% | 5,185,529 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
Jiang Xi Sanxin Medtec Co., Ltd. is a China-based company principally engaged in research, development, manufacture and sales of disposable sterile injection medical devices. The Company's products include five series: syringe series, infusion & transfusion series, catheter tubing series, blood purification series and other series. The Company distributes its products within the domestic markets and to overseas markets.
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.93% | 517M | |
| -3.02% | 185B | |
| -3.78% | 105B | |
| -5.32% | 66.59B | |
| +6.20% | 54.66B | |
| +16.14% | 47.78B | |
| +4.06% | 41.26B | |
| +5.07% | 26.95B | |
| +1.78% | 26.37B | |
| +12.96% | 24.8B |
- Stock Market
- Equities
- 300453 Stock
